• No results found

[PDF] Top 20 Detemir as a once-daily basal insulin in type 2 diabetes

Has 10000 "Detemir as a once-daily basal insulin in type 2 diabetes" found on our website. Below are the top 20 most common "Detemir as a once-daily basal insulin in type 2 diabetes".

Detemir as a once-daily basal insulin in type 2 diabetes

Detemir as a once-daily basal insulin in type 2 diabetes

... with basal and prandial insulin-based regimens (such as detemir + aspart) achieved better A1C control than those receiving biphasic insulin therapy by the end of ...or basal group (OR ... See full document

11

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

... and insulin, the majority of patients with type 2 diabetes have difficulty achieving or maintaining target glycemic control with- out associated weight gain ...ating insulin therapy is ... See full document

9

Iowa medicaid 2: lapse of glycemic control on abrupt transition from insulin glargine to insulin detemir in type 2 diabetes mellitus

Iowa medicaid 2: lapse of glycemic control on abrupt transition from insulin glargine to insulin detemir in type 2 diabetes mellitus

... Group 2 continuing insulin glargine, a much larger daily dose of insulin detemir would be required and that too, to be administered twice daily in majority of subjects ...of ... See full document

5

Insulin detemir for the treatment of obese patients with type 2 diabetes

Insulin detemir for the treatment of obese patients with type 2 diabetes

... developing type 2 diabetes (T2DM) is greater among obese ...human insulin formulations. Insulin detemir is a neutral, soluble, long-acting insulin analog in which ... See full document

9

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review

... both insulin detemir and glargine as derived with the glucose clamp ...with type 1 diabetes. The dose range may be higher in type 2 ...action, detemir demonstrates less ... See full document

6

Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

... with type 2 diabetes mellitus (T2DM) ul- timately require insulin to maintain glycaemic ...which insulin regimens are optimal to start the treat- ment cascade of the disease ...[1]. ... See full document

9

The role of insulin detemir in overweight type 2 diabetes management

The role of insulin detemir in overweight type 2 diabetes management

... Insulin detemir is a novel soluble long-acting insulin ana- logue which is proven to be both safe and effective for use in type 2 ...a basal-bolus regimen or as add- on to ... See full document

8

Original Article Comparative research on insulin detemir combined with repaglinide and insulin aspart 30 in treating aged type 2 diabetes mellitus

Original Article Comparative research on insulin detemir combined with repaglinide and insulin aspart 30 in treating aged type 2 diabetes mellitus

... with type 2 diabetes mellitus (T2DM). The selection of insulin in elderly patients should be smooth in lowering blood glucose, and as far as possible to reduce blood glucose fluctuation, ... See full document

6

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

... of detemir with glargine in a basal-bolus regimen in patients with type 2 ...trial. Type 2 DM patients who had been receiving an OAD or insulin (with or without OADs) were ... See full document

12

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes

... of insulin detemir have been investigated in a series of glycemic clamp ...with type 1 diabetes administered insulin detemir in a repeat clamp study, and this was refl ected in ... See full document

10

<p>Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia</p>

<p>Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Na&iuml;ve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia</p>

... for diabetes-related complications and added new risk equations for diabetes ulcers, all-cause mortality and some second ...National Diabetes Registry ...(insulin Detemir), which ... See full document

11

Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study

... Basal insulin analogues such as insulin detemir were developed using recombinant techniques to provide a more physiological profile than human intermediate insulin preparations, and ... See full document

10

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients

... Another limitation concerns the possibility of residual confounding. The existence of co-morbidities in T2D pa- tients may influence insulin utilisation, but was not in- cluded in the multivariate regression ... See full document

6

Twice- rather than once-daily basal insulin is associated with better glycaemic control in Type 1 diabetes mellitus 12 months after skills-based structured education in insulin self-management

Twice- rather than once-daily basal insulin is associated with better glycaemic control in Type 1 diabetes mellitus 12 months after skills-based structured education in insulin self-management

... than basal insulin ...between basal insulin types with a tendency towards more events in glargine users compared with NPH and ...different basal regi- ...twice-daily basal ... See full document

6

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

... premixed insulin regimen with a once-daily basal insulin plus once-daily prandial insu- lin regimen in patients with T2DM not adequately controlled on insulin ... See full document

8

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring

... for insulin glargine, it was deemed inappropriate to continue enrolling patients to receive insulin ...with type 1 and type 2 diabetes were ...Figure 2, most of the ... See full document

6

Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now?

Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now?

... study, insulin glargine provided a greater metabolic activity and superior glucose control for up 32 h, with a mean GIR0-32 h, a surrogate measure of insulin metabolic activity, that was 31% greater than ... See full document

6

From insulin detemir to glargine: Effect on glycemic control and psychological wellbeing in patients with diabetes mellitus type 2 in daily practice

From insulin detemir to glargine: Effect on glycemic control and psychological wellbeing in patients with diabetes mellitus type 2 in daily practice

... mellitus type 2 (DM2) is characterized by insulin resistance and a progressive decline of the insulin secretory ...with insulin, with our without the combination with oral glucose low- ... See full document

8

Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus

Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus

... and insulin treatment. Basal insulin units were decreased signifi- cantly in patients with both type 1 and type 2 diabetes mel- litus (Table 3), but improvement of QOL was ... See full document

7

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics

... the insulin detemir clinical trials program was of reduced weight gain versus both NPH insulin and insulin glargine (Tables 1, 2, and ...in type 1 diabetes, insulin ... See full document

17

Show all 10000 documents...